25 XP   0   0   10

Zhejiang Xinguang Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Xinguang Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Xinguang Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Xinguang Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Xinguang Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Xinguang Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Xinguang Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Xinguang Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.33
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.37
Expected worth in 1 year
¥5.69
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.72
Return On Investment
22.9%

For what price can you sell your share?

Current Price per Share
¥11.84
Expected price per share
¥8.45 - ¥13.72
How sure are you?
50%

1. Valuation of Zhejiang Xinguang Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥11.84

Intrinsic Value Per Share

¥4.99 - ¥8.61

Total Value Per Share

¥10.36 - ¥13.98

2. Growth of Zhejiang Xinguang Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Xinguang Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$118.5m$116.7m$1.7m1.5%

How much money is Zhejiang Xinguang Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$15m$15.7m-$753.3k-5.0%
Net Profit Margin31.0%35.6%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Xinguang Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Xinguang Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Xinguang Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Xinguang Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Xinguang Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Xinguang Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Xinguang Pharmaceutical Co Ltd is ¥11.84. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Xinguang Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Xinguang Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.37. Based on the TTM, the Book Value Change Per Share is ¥0.08 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.60 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Xinguang Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.090.8%0.090.8%0.100.8%0.090.7%0.070.6%
Usd Book Value Change Per Share0.010.1%0.010.1%0.020.1%0.030.2%0.060.5%
Usd Dividend Per Share0.080.7%0.080.7%0.080.7%0.060.5%0.050.4%
Usd Total Gains Per Share0.090.8%0.090.8%0.100.8%0.090.7%0.110.9%
Usd Price Per Share2.16-2.16-2.79-2.19-2.48-
Price to Earnings Ratio23.02-23.02-28.27-25.08-26.41-
Price-to-Total Gains Ratio23.06-23.06-28.02-25.02-27.75-
Price to Book Ratio2.92-2.92-3.82-3.10-4.02-
Price-to-Total Gains Ratio23.06-23.06-28.02-25.02-27.75-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.63392
Number of shares612
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.080.06
Usd Book Value Change Per Share0.010.03
Usd Total Gains Per Share0.090.09
Gains per Quarter (612 shares)57.3753.32
Gains per Year (612 shares)229.46213.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12032721914965203
240554448297129416
360880677446194629
4811107906595259842
5101313411357433231055
6121616113648923881268
71419187159310404531481
81622214182211895171694
91824241205113385821907
102027268228014866462120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.02.080.0%8.00.04.066.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%

Fundamentals of Zhejiang Xinguang Pharmaceutical Co Ltd

About Zhejiang Xinguang Pharmaceutical Co Ltd

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food. It offers pharmaceutical products for vascular and trauma diseases, including respiratory system, digestive system, urinary system, pediatric diseases, and improving immunity. The company was incorporated in 1998 and is headquartered in Shengzhou, China.

Fundamental data was last updated by Penke on 2024-04-16 15:47:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Zhejiang Xinguang Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Xinguang Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Xinguang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 31.0% means that ¥0.31 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The MRQ is 31.0%. The company is making a huge profit. +2
  • The TTM is 31.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ31.0%TTM31.0%0.0%
TTM31.0%YOY35.6%-4.7%
TTM31.0%5Y33.1%-2.2%
5Y33.1%10Y27.6%+5.6%
1.1.2. Return on Assets

Shows how efficient Zhejiang Xinguang Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Xinguang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 11.4% Return on Assets means that Zhejiang Xinguang Pharmaceutical Co Ltd generated ¥0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The MRQ is 11.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 11.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ11.4%TTM11.4%0.0%
TTM11.4%YOY12.3%-0.9%
TTM11.4%5Y11.3%+0.1%
5Y11.3%10Y12.0%-0.7%
1.1.3. Return on Equity

Shows how efficient Zhejiang Xinguang Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Xinguang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 12.7% Return on Equity means Zhejiang Xinguang Pharmaceutical Co Ltd generated ¥0.13 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The MRQ is 12.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.7%TTM12.7%0.0%
TTM12.7%YOY13.5%-0.8%
TTM12.7%5Y12.3%+0.4%
5Y12.3%10Y13.4%-1.0%

1.2. Operating Efficiency of Zhejiang Xinguang Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Xinguang Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Xinguang Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Xinguang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 32.2% means the company generated ¥0.32  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The MRQ is 32.2%. The company is operating very efficient. +2
  • The TTM is 32.2%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ32.2%TTM32.2%0.0%
TTM32.2%YOY33.9%-1.7%
TTM32.2%5Y32.3%-0.1%
5Y32.3%10Y28.7%+3.6%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Xinguang Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are ¥1.16 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The MRQ is 1.160. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.160. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.160TTM1.1600.000
TTM1.160YOY1.098+0.062
TTM1.1605Y1.129+0.031
5Y1.12910Y0.933+0.195

1.3. Liquidity of Zhejiang Xinguang Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Xinguang Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 9.19 means the company has ¥9.19 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The MRQ is 9.192. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.192. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.192TTM9.1920.000
TTM9.192YOY10.448-1.256
TTM9.1925Y11.846-2.655
5Y11.84610Y8.754+3.092
1.3.2. Quick Ratio

Measures if Zhejiang Xinguang Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Xinguang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.57 means the company can pay off ¥1.57 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The MRQ is 1.571. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.571. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.571TTM1.5710.000
TTM1.571YOY1.897-0.326
TTM1.5715Y2.734-1.163
5Y2.73410Y2.362+0.372

1.4. Solvency of Zhejiang Xinguang Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Xinguang Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Xinguang Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.10 means that Zhejiang Xinguang Pharmaceutical Co Ltd assets are financed with 10.3% credit (debt) and the remaining percentage (100% - 10.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The MRQ is 0.103. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.103. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.103TTM0.1030.000
TTM0.103YOY0.092+0.011
TTM0.1035Y0.085+0.019
5Y0.08510Y0.110-0.026
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Xinguang Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Xinguang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 11.5% means that company has ¥0.12 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The MRQ is 0.115. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.115. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.115TTM0.1150.000
TTM0.115YOY0.102+0.013
TTM0.1155Y0.093+0.023
5Y0.09310Y0.126-0.034

2. Market Valuation of Zhejiang Xinguang Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Xinguang Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Xinguang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 23.02 means the investor is paying ¥23.02 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The EOD is 17.408. Based on the earnings, the company is fair priced.
  • The MRQ is 23.025. Based on the earnings, the company is fair priced.
  • The TTM is 23.025. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD17.408MRQ23.025-5.617
MRQ23.025TTM23.0250.000
TTM23.025YOY28.267-5.242
TTM23.0255Y25.075-2.050
5Y25.07510Y26.409-1.334
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The EOD is 17.256. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 22.823. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 22.823. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD17.256MRQ22.823-5.567
MRQ22.823TTM22.8230.000
TTM22.823YOY25.308-2.485
TTM22.8235Y26.085-3.263
5Y26.08510Y29.513-3.427
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Xinguang Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Xinguang Pharmaceutical Co Ltd:

  • The EOD is 2.206. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.917. Based on the equity, the company is underpriced. +1
  • The TTM is 2.917. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.206MRQ2.917-0.712
MRQ2.917TTM2.9170.000
TTM2.917YOY3.817-0.900
TTM2.9175Y3.095-0.178
5Y3.09510Y4.019-0.924
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Xinguang Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0790.0790%0.120-34%0.191-59%0.448-82%
Book Value Per Share--5.3685.3680%5.289+1%5.106+5%3.870+39%
Current Ratio--9.1929.1920%10.448-12%11.846-22%8.754+5%
Debt To Asset Ratio--0.1030.1030%0.092+12%0.085+22%0.110-7%
Debt To Equity Ratio--0.1150.1150%0.102+13%0.093+24%0.126-9%
Dividend Per Share--0.6000.6000%0.6000%0.440+36%0.328+83%
Eps--0.6800.6800%0.714-5%0.630+8%0.530+28%
Free Cash Flow Per Share--0.6860.6860%0.798-14%0.617+11%0.578+19%
Free Cash Flow To Equity Per Share--0.0860.0860%0.198-56%0.177-51%0.428-80%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.800+25%
Intrinsic Value_10Y_max--8.608--------
Intrinsic Value_10Y_min--4.990--------
Intrinsic Value_1Y_max--0.743--------
Intrinsic Value_1Y_min--0.564--------
Intrinsic Value_3Y_max--2.323--------
Intrinsic Value_3Y_min--1.649--------
Intrinsic Value_5Y_max--4.014--------
Intrinsic Value_5Y_min--2.676--------
Market Cap1894400000.000-32%2505600000.0002505600000.0000%3230400000.000-22%2535040000.000-1%2879520000.000-13%
Net Profit Margin--0.3100.3100%0.356-13%0.331-7%0.276+12%
Operating Margin--0.3220.3220%0.339-5%0.3230%0.287+12%
Operating Ratio--1.1601.1600%1.098+6%1.129+3%0.933+24%
Pb Ratio2.206-32%2.9172.9170%3.817-24%3.095-6%4.019-27%
Pe Ratio17.408-32%23.02523.0250%28.267-19%25.075-8%26.409-13%
Price Per Share11.840-32%15.66015.6600%20.190-22%15.844-1%17.997-13%
Price To Free Cash Flow Ratio17.256-32%22.82322.8230%25.308-10%26.085-13%29.513-23%
Price To Total Gains Ratio17.431-32%23.05523.0550%28.024-18%25.024-8%27.750-17%
Quick Ratio--1.5711.5710%1.897-17%2.734-43%2.362-33%
Return On Assets--0.1140.1140%0.123-7%0.113+1%0.120-5%
Return On Equity--0.1270.1270%0.135-6%0.123+3%0.134-5%
Total Gains Per Share--0.6790.6790%0.720-6%0.631+8%0.776-13%
Usd Book Value--118527448.070118527448.0700%116777955.846+1%112746679.269+5%85444298.166+39%
Usd Book Value Change Per Share--0.0110.0110%0.017-34%0.026-59%0.062-82%
Usd Book Value Per Share--0.7410.7410%0.730+1%0.705+5%0.534+39%
Usd Dividend Per Share--0.0830.0830%0.0830%0.061+36%0.045+83%
Usd Eps--0.0940.0940%0.099-5%0.087+8%0.073+28%
Usd Free Cash Flow--15150277.47315150277.4730%17614675.906-14%13621871.161+11%12758754.158+19%
Usd Free Cash Flow Per Share--0.0950.0950%0.110-14%0.085+11%0.080+19%
Usd Free Cash Flow To Equity Per Share--0.0120.0120%0.027-56%0.024-51%0.059-80%
Usd Market Cap261427200.000-32%345772800.000345772800.0000%445795200.000-22%349835520.000-1%397373760.000-13%
Usd Price Per Share1.634-32%2.1612.1610%2.786-22%2.186-1%2.484-13%
Usd Profit--15017299.38815017299.3880%15770689.560-5%13909687.801+8%11700695.027+28%
Usd Revenue--48505455.86348505455.8630%44280898.314+10%42033823.570+15%41661270.232+16%
Usd Total Gains Per Share--0.0940.0940%0.099-6%0.087+8%0.107-13%
 EOD+4 -4MRQTTM+0 -0YOY+8 -255Y+20 -1510Y+22 -14

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Xinguang Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.408
Price to Book Ratio (EOD)Between0-12.206
Net Profit Margin (MRQ)Greater than00.310
Operating Margin (MRQ)Greater than00.322
Quick Ratio (MRQ)Greater than11.571
Current Ratio (MRQ)Greater than19.192
Debt to Asset Ratio (MRQ)Less than10.103
Debt to Equity Ratio (MRQ)Less than10.115
Return on Equity (MRQ)Greater than0.150.127
Return on Assets (MRQ)Greater than0.050.114
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Xinguang Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.486
Ma 20Greater thanMa 5012.337
Ma 50Greater thanMa 10012.238
Ma 100Greater thanMa 20014.168
OpenGreater thanClose11.710
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets957,759
Total Liabilities98,865
Total Stockholder Equity858,895
 As reported
Total Liabilities 98,865
Total Stockholder Equity+ 858,895
Total Assets = 957,759

Assets

Total Assets957,759
Total Current Assets812,263
Long-term Assets145,496
Total Current Assets
Cash And Cash Equivalents 622,030
Short-term Investments 115,000
Net Receivables 23,805
Inventory 46,147
Other Current Assets 3,566
Total Current Assets  (as reported)812,263
Total Current Assets  (calculated)810,548
+/- 1,715
Long-term Assets
Property Plant Equipment 114,882
Intangible Assets 9,283
Other Assets 958
Long-term Assets  (as reported)145,496
Long-term Assets  (calculated)125,124
+/- 20,372

Liabilities & Shareholders' Equity

Total Current Liabilities88,368
Long-term Liabilities10,497
Total Stockholder Equity858,895
Total Current Liabilities
Accounts payable 56,747
Other Current Liabilities 26,774
Total Current Liabilities  (as reported)88,368
Total Current Liabilities  (calculated)83,521
+/- 4,847
Long-term Liabilities
Other Liabilities 10,497
Long-term Liabilities  (as reported)10,497
Long-term Liabilities  (calculated)10,497
+/- 0
Total Stockholder Equity
Common Stock160,000
Retained Earnings 535,190
Other Stockholders Equity 2,415
Total Stockholder Equity (as reported)858,895
Total Stockholder Equity (calculated)697,606
+/- 161,289
Other
Capital Stock160,000
Common Stock Shares Outstanding 160,000
Net Invested Capital 858,895
Net Tangible Assets 849,612
Net Working Capital 723,895
Property Plant and Equipment Gross 114,882



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
219,352
217,438
246,259
303,096
362,870
700,951
775,047
822,500
861,131
890,786
932,404
957,759
957,759932,404890,786861,131822,500775,047700,951362,870303,096246,259217,438219,352
   > Total Current Assets 
0
0
0
0
245,504
570,857
623,140
662,178
698,408
742,895
785,915
812,263
812,263785,915742,895698,408662,178623,140570,857245,5040000
       Cash And Cash Equivalents 
61,762
81,515
101,308
122,620
175,362
336,633
376,540
406,490
407,353
591,848
593,668
622,030
622,030593,668591,848407,353406,490376,540336,633175,362122,620101,30881,51561,762
       Short-term Investments 
0
0
0
0
0
150,000
168,000
178,000
218,000
85,000
125,000
115,000
115,000125,00085,000218,000178,000168,000150,00000000
       Net Receivables 
20,170
24,671
33,290
43,871
35,064
37,168
30,463
20,252
21,567
19,035
17,668
23,805
23,80517,66819,03521,56720,25230,46337,16835,06443,87133,29024,67120,170
       Other Current Assets 
1,086
189
112
2,876
4,416
6,077
4,864
2,431
2,252
2,363
2,818
3,566
3,5662,8182,3632,2522,4314,8646,0774,4162,8761121891,086
   > Long-term Assets 
0
0
0
0
0
130,094
151,908
160,322
162,723
147,890
146,489
145,496
145,496146,489147,890162,723160,322151,908130,09400000
       Property Plant Equipment 
56,137
47,467
48,812
65,316
75,415
90,542
113,918
123,575
124,467
112,842
114,675
114,882
114,882114,675112,842124,467123,575113,91890,54275,41565,31648,81247,46756,137
       Long Term Investments 
0
0
0
0
29,843
28,306
27,348
26,706
0
0
0
0
000026,70627,34828,30629,8430000
       Intangible Assets 
18,399
11,092
10,808
10,524
10,240
10,139
9,832
9,603
12,675
11,545
10,414
9,283
9,28310,41411,54512,6759,6039,83210,13910,24010,52410,80811,09218,399
       Long-term Assets Other 
0
0
0
0
0
130,094
151,908
160,322
162,723
0
0
0
000162,723160,322151,908130,09400000
> Total Liabilities 
115,032
75,815
44,291
54,098
53,518
60,487
69,238
69,240
61,420
63,843
86,187
98,865
98,86586,18763,84361,42069,24069,23860,48753,51854,09844,29175,815115,032
   > Total Current Liabilities 
112,365
72,639
40,362
42,527
41,694
48,953
57,908
58,066
49,933
52,312
75,222
88,368
88,36875,22252,31249,93358,06657,90848,95341,69442,52740,36272,639112,365
       Accounts payable 
51,449
44,085
24,584
22,350
24,125
31,187
42,042
46,012
35,391
36,326
56,115
56,747
56,74756,11536,32635,39146,01242,04231,18724,12522,35024,58444,08551,449
       Other Current Liabilities 
10,915
6,554
12,778
19,177
9,962
9,196
6,758
5,138
5,536
6,235
6,221
26,774
26,7746,2216,2355,5365,1386,7589,1969,96219,17712,7786,55410,915
   > Long-term Liabilities 
0
0
0
0
0
11,533
11,330
11,173
11,488
11,531
10,965
10,497
10,49710,96511,53111,48811,17311,33011,53300000
> Total Stockholder Equity
102,310
141,623
201,968
248,997
309,352
640,464
705,809
753,260
799,710
826,943
846,217
858,895
858,895846,217826,943799,710753,260705,809640,464309,352248,997201,968141,623102,310
   Common Stock
15,000
60,000
60,000
60,000
60,000
80,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000160,000160,000160,000160,000160,00080,00060,00060,00060,00060,00015,000
   Retained Earnings 
85,310
31,593
92,062
137,714
196,498
315,457
381,616
429,612
475,993
503,449
522,369
535,190
535,190522,369503,449475,993429,612381,616315,457196,498137,71492,06231,59385,310
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
0
0
5,025
3,718
2,904
2,359
2,429
2,205
2,559
2,415
2,4152,5592,2052,4292,3592,9043,7185,0250000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue305,151
Cost of Revenue-167,795
Gross Profit137,357137,357
 
Operating Income (+$)
Gross Profit137,357
Operating Expense-233,119
Operating Income72,032-95,762
 
Operating Expense (+$)
Research Development15,637
Selling General Administrative33,902
Selling And Marketing Expenses-
Operating Expense233,11949,539
 
Net Interest Income (+$)
Interest Income5,190
Interest Expense--
Other Finance Cost-9,164
Net Interest Income14,354
 
Pretax Income (+$)
Operating Income72,032
Net Interest Income14,354
Other Non-Operating Income Expenses-
Income Before Tax (EBT)89,77072,032
EBIT - interestExpense = 0
78,124
78,124
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-89,770
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax89,770
Tax Provision-11,646
Net Income From Continuing Ops78,12478,124
Net Income78,124
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--14,354
 

Technical Analysis of Zhejiang Xinguang Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Xinguang Pharmaceutical Co Ltd. The general trend of Zhejiang Xinguang Pharmaceutical Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Xinguang Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Xinguang Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.30 < 13.61 < 13.72.

The bearish price targets are: 11.01 > 8.45.

Tweet this
Zhejiang Xinguang Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Xinguang Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Xinguang Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Xinguang Pharmaceutical Co Ltd. The current macd is -0.32470006.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Xinguang Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Xinguang Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Xinguang Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Xinguang Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Xinguang Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Xinguang Pharmaceutical Co Ltd. The current adx is 21.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zhejiang Xinguang Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Zhejiang Xinguang Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Xinguang Pharmaceutical Co Ltd. The current sar is 12.10.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Xinguang Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Xinguang Pharmaceutical Co Ltd. The current rsi is 44.49. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Zhejiang Xinguang Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Xinguang Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Xinguang Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Xinguang Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Xinguang Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Xinguang Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Xinguang Pharmaceutical Co Ltd. The current cci is -64.01063953.

Zhejiang Xinguang Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Xinguang Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Xinguang Pharmaceutical Co Ltd. The current cmo is -10.22582624.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Xinguang Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Xinguang Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Xinguang Pharmaceutical Co Ltd. The current willr is -63.75545852.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zhejiang Xinguang Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhejiang Xinguang Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Xinguang Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Xinguang Pharmaceutical Co Ltd.

Zhejiang Xinguang Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Xinguang Pharmaceutical Co Ltd. The current atr is 0.52233435.

Zhejiang Xinguang Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Xinguang Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Xinguang Pharmaceutical Co Ltd. The current obv is 87,624,172.

Zhejiang Xinguang Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Xinguang Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Xinguang Pharmaceutical Co Ltd. The current mfi is 36.21.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Xinguang Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Xinguang Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Xinguang Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Zhejiang Xinguang Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Xinguang Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.486
Ma 20Greater thanMa 5012.337
Ma 50Greater thanMa 10012.238
Ma 100Greater thanMa 20014.168
OpenGreater thanClose11.710
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Xinguang Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Xinguang Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Xinguang Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Xinguang Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Xinguang Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Xinguang Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Xinguang Pharmaceutical Co Ltd in your mailbox!